JP2006517788A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517788A5
JP2006517788A5 JP2005509989A JP2005509989A JP2006517788A5 JP 2006517788 A5 JP2006517788 A5 JP 2006517788A5 JP 2005509989 A JP2005509989 A JP 2005509989A JP 2005509989 A JP2005509989 A JP 2005509989A JP 2006517788 A5 JP2006517788 A5 JP 2006517788A5
Authority
JP
Japan
Prior art keywords
antibody
cancer
polypeptide
composition
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005509989A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517788A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/040226 external-priority patent/WO2004058153A2/en
Publication of JP2006517788A publication Critical patent/JP2006517788A/ja
Publication of JP2006517788A5 publication Critical patent/JP2006517788A5/ja
Pending legal-status Critical Current

Links

JP2005509989A 2002-12-20 2003-12-16 １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物 Pending JP2006517788A (ja)

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US43510802P 2002-12-20 2002-12-20
US43644302P 2002-12-23 2002-12-23
US43849803P 2003-01-07 2003-01-07
US44437003P 2003-01-31 2003-01-31
US44603103P 2003-02-06 2003-02-06
US45363503P 2003-03-11 2003-03-11
US45719903P 2003-03-25 2003-03-25
US46245803P 2003-04-10 2003-04-10
US46673203P 2003-04-30 2003-04-30
US46918403P 2003-05-08 2003-05-08
US47166303P 2003-05-19 2003-05-19
US47547203P 2003-06-03 2003-06-03
US47815003P 2003-06-12 2003-06-12
US48063103P 2003-06-23 2003-06-23
US48736903P 2003-07-15 2003-07-15
US49086603P 2003-07-29 2003-07-29
US49961403P 2003-09-02 2003-09-02
US51008103P 2003-10-09 2003-10-09
US51774203P 2003-11-06 2003-11-06
PCT/US2003/040226 WO2004058153A2 (en) 2002-12-20 2003-12-16 Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.

Publications (2)

Publication Number Publication Date
JP2006517788A JP2006517788A (ja) 2006-08-03
JP2006517788A5 true JP2006517788A5 (https=) 2006-12-07

Family

ID=32686484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005509989A Pending JP2006517788A (ja) 2002-12-20 2003-12-16 １５９８６、２１８８、２０７４３、９１４８、９１５１、９７９１、４４２５２、１４１８４、４２４６１、８２０４、７９７０、２５５５２、２１６５７、２６４９２、２４１１、１５０８８、１９０５、２８８９９、６３３８０、３３９３５、１０４８０、１２６８６、２５５０１、１７６９４、１５７０１、５３０６２、４９９０８、２１６１２、３８９４９、６２１６、４６８６３、９２３５、２２０１、６９８５、９８８３、１２２３８、１８０５７、２１６１７、３９２２８、４９９２８、５４４７６、６２１１３、６４３１６、１２２６４、３２３６２、５８１９８、２８８７、３２０５、８５５７、９６００、９６９３、４４８６７、５３０５８、５５５５６、５７６５８、２２０８、１０２５２、１０３０２、１４２１８、３３８７７、１０３１７、１０４８５、２５９６４、１４８１５、１３６３、１３９７、１４８２７、２１７０８、３８０１、６４６９８、２１７９または１３２４９を使用する癌を処置するための方法および組成物

Country Status (5)

Country Link
US (1) US20040235071A1 (https=)
EP (1) EP1572118A4 (https=)
JP (1) JP2006517788A (https=)
AU (1) AU2003297318A1 (https=)
WO (1) WO2004058153A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080050836A1 (en) * 1998-05-01 2008-02-28 Isabelle Guyon Biomarkers for screening, predicting, and monitoring benign prostate hyperplasia
AU1891601A (en) * 1999-12-16 2001-06-25 Chugai Research Institute For Molecular Medicine, Inc. Novel human RNA helicase, helicain
US20090226915A1 (en) * 2001-01-24 2009-09-10 Health Discovery Corporation Methods for Screening, Predicting and Monitoring Prostate Cancer
US20030153018A1 (en) * 2001-11-27 2003-08-14 Millennium Pharmaceuticals, Inc. Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
US8008012B2 (en) 2002-01-24 2011-08-30 Health Discovery Corporation Biomarkers downregulated in prostate cancer
US20070134660A1 (en) * 2003-05-30 2007-06-14 Rosetta Inpharmatics Llc Methods for identifying modulators of kinesin activity
US7534562B2 (en) 2003-09-30 2009-05-19 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthetase gene
US20100022625A1 (en) * 2006-06-29 2010-01-28 Srivastava Satish K Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
US20070021366A1 (en) 2004-11-19 2007-01-25 Srivastava Satish K Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
US11105808B2 (en) 2004-11-12 2021-08-31 Health Discovery Corporation Methods for screening, predicting and monitoring prostate cancer
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
DE102004059781A1 (de) * 2004-12-10 2006-06-22 Sanofi-Aventis Deutschland Gmbh Verwendung der Serum-/Glucocorticoid regulierten Kinase
US20100151572A1 (en) * 2005-05-16 2010-06-17 Sorscher Eric J Anti-tumoral compositions methods
WO2007037473A1 (ja) * 2005-09-30 2007-04-05 Daiichi Pharmaceutical Co., Ltd. 細胞遊走阻害方法および細胞遊走阻害剤
US20070092585A1 (en) * 2005-10-14 2007-04-26 Skinner Michael K Cancer chemotherapy compositions comprising PI3K pathways modulators and triptolide
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
NZ592461A (en) 2008-10-22 2012-12-21 Oncotherapy Science Inc Rab6kifl/kif20a epitope peptide and vaccines containing the same
WO2010096154A2 (en) * 2009-02-20 2010-08-26 Onconome, Inc. Compositions and methods for diagnosis and prognosis of colorectal cancer
EP2249159A1 (en) * 2009-04-29 2010-11-10 Ganymed Pharmaceuticals AG Identification of tumor-associated markers for diagnosis and therapy
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Ｋｎｔｃ２胜肽及含此胜肽之疫苗
EP2806274A1 (en) * 2013-05-24 2014-11-26 AIT Austrian Institute of Technology GmbH Lung cancer diagnostic method and means
WO2021007527A1 (en) * 2019-07-11 2021-01-14 University Of Utah Research Foundation Compositions and methods for treating peroxisomal biogenesis disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1108021A2 (en) * 1998-08-31 2001-06-20 Bayer Corporation Human genes differentially expressed in colorectal cancer
MXPA01009688A (es) * 1999-03-26 2002-03-27 Smithkline Beecham Biolog Compuestos novedosos.
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
KR100876327B1 (ko) * 2001-02-21 2008-12-31 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 진단에서의, 그리고 암에서 치료 표적으로서의 ｔｔｋ
AU2002319180B2 (en) * 2001-05-23 2007-07-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Pyruvate-kinase as a novel target molecule
WO2002098891A2 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE

Similar Documents

Publication Publication Date Title
JP2006517788A5 (https=)
Otieno et al. On-line protein capture on magnetic beads for ultrasensitive microfluidic immunoassays of cancer biomarkers
Otieno et al. Cancer diagnostics via ultrasensitive multiplexed detection of parathyroid hormone-related peptides with a microfluidic immunoarray
CN104198707B (zh) N-乙酰氨基葡萄糖在制备检测肿瘤的试剂盒中的应用
CN104267185B (zh) 检测肿瘤的试剂盒及其专用识别n-乙酰氨基葡萄糖的物质
de Gracia Villa et al. Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis
JP2008209323A (ja) 酵素センサ、該酵素センサを使用した分析方法及びキット
Mihoc et al. Antibody epitope and affinity determination of the myocardial infarction marker myoglobin by SPR-biosensor mass spectrometry
Kim et al. Dual synergistic response for the electrochemical detection of H1N1 virus and viral proteins using high affinity peptide receptors
JP2001526644A (ja) 結腸直腸ガンの診断、ならびにこの診断における使用のためのタンパク質および抗体
Özçelikay-Akyıldız et al. Ultrasensitive electrochemical immunosensor system for determination of autologous SOX2 antibody
Tok et al. Simple workflow to repurpose SARS-CoV-2 swab/serum samples for the isolation of cost-effective antibody/antigens for proteotyping applications and diagnosis
Seo et al. Sandwich antibody arrays using recombinant antibody-binding protein L
JP2005516604A5 (https=)
JP2005525112A5 (https=)
US20100221742A1 (en) Novel cancer associated antibodies and their use in cancer diagnosis
JP2005508169A5 (https=)
CN103848889B (zh) Igf2bp1自身抗体识别的抗原多肽
CN111487411A (zh) Ceacam1多肽的新应用
JP2005504830A5 (https=)
JP4850001B2 (ja) 新規ストレスバイオマーカー及びその用途
JP2005508633A5 (https=)
Mesbah et al. Contribution of CE to the analysis of protein or peptide biomarkers
Wu et al. Peptide Biomarkers-An Emerging Diagnostic Tool and Current Applicable Assay
CN116635718A (zh) 用于在免疫组织化学（ihc）方案中使用以诊断癌症的抗人cd10抗体